A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in ...

One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes did not meet its ...

The drug from Cronus Pharma contains the same active ingredient as Boehringer Ingelheim's Vetmedin.

The U.S. Food and Drug Administration recently approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults with ...

A new study indicates that people who have used a vape at any point in their lives are 19% more likely to experience heart ...

About 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure.

In heart failure, "the paradox is that at a time that we're seeing these increases in mortality, we also have access to ...

Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said ...

A new study found that for those who receive a diagnosis of atrial fibrillation, the most common complication is heart ...

Eli Lilly noted that tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults that have both obstructive ...

Type 2 Diabetes is one of the most common causes of Chronic Kidney Disease where the kidneys become far too damaged and ...

Eli Lilly (NYSE: LLY) is a global pharmaceutical leader which has made significant strides in the obesity treatment market ...